Literature DB >> 11248248

Ser(13)-phosphorylated PYY from porcine intestine with a potent biological activity.

Z Chen1, E Eriste, A P Jonsson, A Norberg, D Nepomuceno, T W Lovenberg, T Bergman, S Efendic, H Jörnvall, R Sillard.   

Abstract

We have isolated a posttranslationally modified form of peptide YY (PYY) from porcine intestine and shown by MALDI-TOF and electrospray tandem mass spectrometry that it is phosphorylated at Ser(13). Phospho-PYY exhibits high affinity for binding to neuropeptide Y (NPY) receptors Y1, Y2 and Y5. The IC(50) values with the Y1, Y2, and Y5 receptor subtypes were for NPY 2.4, 3.1, and 3.3 nM, for PYY 2.3, 0.94, and 3.2 nM, and for phospho-PYY 4.6, 2.2, and 5.5 nM, respectively. Phospho-PYY potently inhibits forskolin-stimulated cAMP accumulation in SK-N-MC cells with an IC(50) value of 0.5 nM compared to 0.15 nM for non-phosphorylated PYY. The finding of phosphorylation of PYY is unusual among hormonal peptides, and emphasizes the importance of direct protein analysis of gene products.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248248     DOI: 10.1016/s0014-5793(01)02234-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Effects of glycine-extended and serine13-phosphorylated forms of peptide YY on food intake in rats.

Authors:  Roger Reidelberger; Alvin Haver; Prasanth Chelikani; David A Keire; Joseph R Reeve
Journal:  Peptides       Date:  2011-01-22       Impact factor: 3.750

2.  PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats.

Authors:  J E Blevins; P K Chelikani; A C Haver; R D Reidelberger
Journal:  Peptides       Date:  2007-11-17       Impact factor: 3.750

3.  Salivary PYY: a putative bypass to satiety.

Authors:  Andres Acosta; Maria D Hurtado; Oleg Gorbatyuk; Michael La Sala; David Duncan; George Aslanidi; Martha Campbell-Thompson; Lei Zhang; Herbert Herzog; Antonis Voutetakis; Bruce J Baum; Sergei Zolotukhin
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.